- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07742397
Fall Risk in Adults Over 65: The Relevance of Morphological and Functional Lower Limb Asymmetries. (ASY&FALL)
29. juli 2026 opdateret af: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Fall-risk Prevention in Adults Over 65: the Relevance of Morphological and Functional Asymmetries of the Lower Limbs.
Falls among older adults represent a major public health burden.
Approximately 30% of individuals aged 65 and older experience at least one fall each year.
These events can lead not only to increased anxiety, depression, and reduced quality of life but also to serious injuries or even death.
Key risk factors include muscle weakness, gait disturbances, and balance impairments.
Lower limb asymmetry-referring to differences in strength, flexibility, composition, or functional capacity between the two legs-has emerged as a potentially important yet underexplored contributor to fall risk in the elderly population.
While asymmetry is frequently studied in the context of sports and physical performance, where it may affect both injury risk and athletic outcomes, its implications for balance and mobility in older adults remain insufficiently investigated.
This study aims to examine the relationship between lower limb asymmetries and fall risk, with the goal of identifying predictive indicators and informing the development of more effective fall prevention strategies.
Ultimately, a better understanding of this relationship could contribute to improved quality of life for older adults and a reduction in healthcare costs associated with fall-related hospitalizations.
Studieoversigt
Status
Rekruttering
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Anslået)
90
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Milan
-
Milan, Milan, Italien
- Rekruttering
- IRCCS Ospedale Galeazzi-Sant'Ambrogio
-
Kontakt:
- Stefano Borghi, Md
- Telefonnummer: 0283502246
- E-mail: stefano.borghi@grupposandonato.it
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Ældre voksen
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Men and women between the ages of 65 yr, able to walk without assistance, lived independently, and had no major cardiovascular, muscular, skeletal or neurological conditions participated in the study.
Beskrivelse
Inclusion Criteria:
- Male or female, of any ethnicity.
- Age ≥ 65 years.
- Cognitively intact.
- Independent ambulation.
- Signed and accepted informed consent to participate in all procedures required for the study.
Exclusion Criteria:
- Previous surgical treatments for orthopedic conditions performed within the six months prior to study inclusion.
- Severe cardiac, pulmonary, or musculoskeletal disorders that may influence the assessment outcomes.
- Comorbidities associated with increased fall risk, such as Parkinson's disease or stroke.
- Body Mass Index ≥ 30.0.
- Use of medications that affect motor coordination, balance, or bone and muscle metabolism.
- Active oncological disease.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Timed Up and Go (TUG) test
Tidsramme: At baseline
|
A functional mobility test measuring dynamic balance and gait efficiency.
Participants stand up from a chair, walk 3 meters, turn, return, and sit; longer times indicate higher fall risk.
|
At baseline
|
|
5-Repetition Sit-to-Stand Test (5-rep STS)
Tidsramme: At baseline
|
A lower-limb strength and functional performance test.
Participants rise from a chair five times as quickly as possible; slower performance reflects reduced strength and increased fall risk.
|
At baseline
|
|
Balance test
Tidsramme: At baseline
|
balance assessment is conducted using Baiobit equipment from BTS Bioengineering.
The maximal balance time in monopodalic will be considered (s)
|
At baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Response time assessment
Tidsramme: At baseline
|
A visual reaction-time assessment using programmable light pods.
Participants respond as quickly as possible to randomly illuminated targets by tapping them, allowing measurement of response time, decision speed, and stimulus-reaction efficiency.
Shorter reaction times indicate better neuromotor responsiveness, while longer delays may reflect reduced processing speed and increased fall-risk vulnerability.
|
At baseline
|
|
Gait Analysis
Tidsramme: At baseline
|
A biomechanical assessment of walking performance using motion-capture technology.
Spatiotemporal parameters (e.g., step length, gait speed, foot clearance) are recorded to evaluate dynamic stability, movement symmetry, and functional mobility, providing objective indicators associated with fall risk in older adults.
|
At baseline
|
|
Physical Activity Questionnaire (IPAQ)
Tidsramme: At baseline
|
A self-reported measure of habitual physical activity.
It quantifies weekly frequency and duration of walking, moderate activity, and vigorous activity, providing an estimate of overall activity level relevant to mobility and fall risk.
|
At baseline
|
|
Falls Efficacy Scale-International (FES-I)
Tidsramme: At baseline
|
A validated questionnaire assessing fear of falling and confidence in performing daily activities.
Higher scores indicate greater concern about falling, which is associated with reduced mobility and increased fall risk.
|
At baseline
|
|
SARC-F questionnaire
Tidsramme: At baseline
|
A screening tool for sarcopenia evaluating strength, assistance in walking, rising from a chair, climbing stairs, and fall history.
Higher scores reflect impaired physical function and greater vulnerability to falls.
|
At baseline
|
|
fall risk questionnaire (FRQ)
Tidsramme: At baseline
|
"The Fall Risk Questionnaire (FRQ) is a validated self-assessment tool.
It has demonstrated good ability to identify older adults at risk of falling and to increase awareness of fall risk within this population.
|
At baseline
|
|
Dual-energy X-ray absorptiometry (DEXA)
Tidsramme: At baseline
|
Gold-standard method for assessing body composition.
By using two X-ray energy levels, DEXA provides detailed information on bone mineral content, lean mass, and fat mass.
|
At baseline
|
|
Strength Assessment
Tidsramme: At baseline
|
Bilateral knee and ankle flexor and extensor strength is assessed using a pressure-based dynamometer.
The protocol includes the measurement of Maximum Voluntary Contraction (MVC, N).
All force signals are sampled at high frequency and processed through filtering and normalization procedures to ensure accurate extraction of mechanical parameters.
|
At baseline
|
|
Power assessment
Tidsramme: At baseline
|
Bilateral knee and ankle flexor and extensor power is assessed using a pressure-based dynamometer.
The protocol includes the measurement of Rate of Force Development (RFD, kg/s through standardized isometric contractions.
All force signals are sampled at high frequency and processed through filtering and normalization procedures to ensure accurate extraction of mechanical parameters.
|
At baseline
|
|
High-Density Surface electromyography Assessment (HD-sEMG)
Tidsramme: At baseline
|
Neuromuscular activity of the knee and ankle flexor and extensor are evaluated using high-density surface electromyography (HD-sEMG) with the Sessantaquattro+ system (OTBioelettronica).
The electrode matrices allow spatially detailed mapping of muscle activation.
EMG signals undergo preprocessing including filtering, artifact removal, and time-alignment with strength trials to provide an integrated characterization of neuromuscular function.
|
At baseline
|
|
Dominance test (Step-Up Test)
Tidsramme: At baseline
|
This test identifies lower-limb dominance by observing which limb the participant naturally uses first when stepping onto a raised platform.
|
At baseline
|
|
Dominance test (Kicking Test)
Tidsramme: At baseline
|
This test determines limb dominance based on the leg used to kick a ball or target.
The dominant lower limb is the one the participant naturally selects for kicking.
|
At baseline
|
|
Dominance test (Balance Recovery Test)
Tidsramme: At baseline
|
This test identifies dominance by evaluating which limb the participant relies on to regain stability after a perturbation.
The dominant limb is typically the one that steps first when balance is unexpectedly challenged.
|
At baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
3. februar 2026
Primær færdiggørelse (Anslået)
1. juni 2027
Studieafslutning (Anslået)
1. april 2028
Datoer for studieregistrering
Først indsendt
3. juli 2026
Først indsendt, der opfyldte QC-kriterier
29. juli 2026
Først opslået (Faktiske)
3. august 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. august 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- Asymmetry&Fall - L3060
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .